Recently, somatic KCNJ5 pathogenic variants were not associated with clinical and biochemical outcome in a small group of 38 aldosteronomas with genetic investigation guided by CYP11B2 staining. The gene discussed is CYP11B2; the disease is aldosterone-producing adenoma with seizures and neurological abnormalities.